Edition:
United Kingdom

Thermo Fisher Scientific Inc (TMO.N)

TMO.N on New York Stock Exchange

212.82USD
18 Jun 2018
Change (% chg)

$-2.98 (-1.38%)
Prev Close
$215.80
Open
$213.72
Day's High
$213.72
Day's Low
$211.58
Volume
331,310
Avg. Vol
367,349
52-wk High
$226.34
52-wk Low
$170.07

Select another date:

Thu, May 24 2018

BRIEF-Thermo Fisher Scientific Sets Quarterly Cash Dividend Of $0.17 Per Share

* SETS QUARTERLY CASH DIVIDEND OF $0.17PER SHARE Source text for Eikon: Further company coverage:

BRIEF-Omega Advisors Takes Share Stake In UnitedHealth, Bristol-Myers Squibb

* OMEGA ADVISORS DISSOLVES SHARE STAKE IN AMERICAN AIRLINES - SEC FILING

BRIEF-Spectrum Pharmaceuticals Enters Into A Next-Generation Sequencing Companion Diagnostic Partnership With Thermo Fisher Scientific

* SPECTRUM PHARMACEUTICALS ENTERS INTO A NEXT-GENERATION SEQUENCING COMPANION DIAGNOSTIC PARTNERSHIP WITH THERMO FISHER SCIENTIFIC

BRIEF-Thermo Fisher Scientific Signs New Agreements To Expand Oncomine Dx Target Test

* THERMO FISHER SCIENTIFIC SIGNS NEW AGREEMENTS TO EXPAND ONCOMINE DX TARGET TEST

BRIEF-Globalstar To Merge With Metro Fiber Provider Fiberlight And Acquire Other Assets In Stock Transaction

* GLOBALSTAR TO MERGE WITH METRO FIBER PROVIDER FIBERLIGHT AND ACQUIRE OTHER ASSETS IN STOCK TRANSACTION

BRIEF-Thermo Fisher Reports Q1 GAAP Earnings Of $1.43/Share

* CO IS RAISING 2018 REVENUE GUIDANCE TO A NEW RANGE OF $23.62 BILLION TO $23.86 BILLION

BRIEF-Thermo Fisher Scientific CEO Marc Casper's FY 2017 Total Compenstion Was $22.3 Mln VS $17.8 Mln

* THERMO FISHER SCIENTIFIC CEO MARC N. CASPER'S FY 2017 TOTAL COMPENSTION WAS $22.3 MLN VS $17.8 MLN - SEC FILING Source text: (https://bit.ly/2HqYMsM) Further company coverage:

BRIEF-Ortho Clinical Diagnostics And Thermo Fisher Scientific Agree To Deliver 14 Assays For Use On Ortho's Vitros Systems

* ORTHO CLINICAL DIAGNOSTICS AND THERMO FISHER SCIENTIFIC AGREE TO DELIVER 14 ASSAYS FOR USE ON ORTHO'S VITROS® SYSTEMS

BRIEF-Biocept And Thermo Fisher Scientific Enter Into Technology And Commercial Collaboration

* BIOCEPT AND THERMO FISHER SCIENTIFIC ENTER INTO TECHNOLOGY AND COMMERCIAL COLLABORATION

BRIEF-Thermo Fisher Scientific Acquires Integenx

* THERMO FISHER SCIENTIFIC ACQUIRES INTEGENX, PROVIDER OF LEADING RAPID DNA TECHNOLOGY FOR HUMAN IDENTIFICATION

Select another date: